Corticosteroid (CS)

DRUG3 trials

Sponsors

AbbVie, University of Calgary, Weill Medical College of Cornell University

Conditions

Giant Cell Arteritis (GCA)Oral and Maxillofacial ConditionsRotator Cuff InjuriesTMJ - Oral &Maxillofacial SurgeryTMJ ArthralgiaTMJ Pain

Phase 3

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

CompletedNCT03725202

AbbVieGiant Cell Arteritis (GCA)

Start: 2019-01-24End: 2025-03-11Updated: 2026-02-24

Biologic Augmentation of TMJ Arthroscopy Using BMAC

Not yet recruitingNCT07536399

Weill Medical College of Cornell UniversityOral and Maxillofacial Conditions, TMJ Arthralgia, TMJ - Oral &Maxillofacial Surgery +1

Start: 2026-04-01End: 2028-06-01Target: 20Updated: 2026-04-17

Phase 4

The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial

CompletedNCT04743986

University of CalgaryRotator Cuff Injuries

Start: 2015-03-13End: 2019-06-06Updated: 2021-02-08

Related Papers

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

New England Journal of Medicine2025-04-0241 citations

Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

Arthritis Research & Therapy2024-06-058 citations